149 related articles for article (PubMed ID: 22813903)
1. Erythropoietin use and immunogenicity of hepatitis B virus vaccine in chronic kidney disease patients: a meta-analysis.
Fabrizi F; Dixit V; Martin P; Messa P
Kidney Blood Press Res; 2012; 35(6):504-10. PubMed ID: 22813903
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
Fabrizi F; Dixit V; Messa P; Martin P
Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.
Fabrizi F; Dixit V; Martin P; Messa P
J Viral Hepat; 2011 Dec; 18(12):871-6. PubMed ID: 22093033
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients.
Fabrizi F; Dixit V; Martin P; Messa P
Aliment Pharmacol Ther; 2011 Apr; 33(7):815-21. PubMed ID: 21281319
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.
Fabrizi F; Dixit V; Messa P; Martin P
Aliment Pharmacol Ther; 2010 Sep; 32(6):756-62. PubMed ID: 20662784
[TBL] [Abstract][Full Text] [Related]
6. The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature.
Alavian SM; Tabatabaei SV
Vaccine; 2010 May; 28(22):3773-7. PubMed ID: 20371390
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
Fabrizi F; Ganeshan SV; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(5):789-96. PubMed ID: 16918882
[TBL] [Abstract][Full Text] [Related]
8. Novel perspectives on the hepatitis B virus vaccine in the chronic kidney disease population.
Fabrizi F; Martin P; Messa P
Int J Artif Organs; 2015 Dec; 38(12):625-31. PubMed ID: 26821784
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease.
Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
Aliment Pharmacol Ther; 2004 Nov; 20(10):1053-62. PubMed ID: 15569107
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: the impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease.
Fabrizi F; Dixit V; Martin P; Jadoul M; Messa P
Dig Dis Sci; 2012 May; 57(5):1366-72. PubMed ID: 22143368
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
Alavian SM; Tabatabaei SV
Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Jun; 23(11):1559-66. PubMed ID: 16696803
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population.
Fabrizi F; Dixit V; Bunnapradist S; Martin P
Aliment Pharmacol Ther; 2006 Apr; 23(8):1105-12. PubMed ID: 16611270
[TBL] [Abstract][Full Text] [Related]
14. The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease.
Hassan K; Shternberg L; Alhaj M; Giron R; Reshef R; Barak M; Kristal B
Ren Fail; 2003 May; 25(3):471-8. PubMed ID: 12803511
[TBL] [Abstract][Full Text] [Related]
15. Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?
Ni JD; Xiong YZ; Wang XJ; Xiu LC
Int J STD AIDS; 2013 Feb; 24(2):117-22. PubMed ID: 23467291
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.
Fabrizi F; Dixit V; Magnini M; Elli A; Martin P
Aliment Pharmacol Ther; 2006 Aug; 24(3):497-506. PubMed ID: 16886915
[TBL] [Abstract][Full Text] [Related]
17. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2011 Oct; 18(10):730-7. PubMed ID: 20819147
[TBL] [Abstract][Full Text] [Related]
18. Primary seroresponses to double-dose compared with standard-dose hepatitis B vaccination in patients with chronic kidney disease: a systematic review and meta-analysis.
Mulley WR; Le ST; Ives KE
Nephrol Dial Transplant; 2017 Jan; 32(1):136-143. PubMed ID: 26763670
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş
Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
[TBL] [Abstract][Full Text] [Related]
20. HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysis.
Fabrizi F; Cerutti R; Donato FM; Messa P
Rev Clin Esp (Barc); 2021 Dec; 221(10):600-611. PubMed ID: 34183297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
